NH vs. CURR, KPLT, MOBQ, SJ, ISDR, VIVK, GLE, XBP, TCJH, and MNY
Should you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include CURRENC Group (CURR), Katapult (KPLT), Mobiquity Technologies (MOBQ), Scienjoy (SJ), Issuer Direct (ISDR), Vivakor (VIVK), Global Engine Group (GLE), XBP Europe (XBP), Top KingWin (TCJH), and MoneyHero (MNY). These companies are all part of the "business services" industry.
NantHealth vs.
CURRENC Group (NASDAQ:CURR) and NantHealth (NASDAQ:NH) are both small-cap services companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.
NantHealth received 269 more outperform votes than CURRENC Group when rated by MarketBeat users. However, 66.67% of users gave CURRENC Group an outperform vote while only 46.80% of users gave NantHealth an outperform vote.
CURRENC Group has a beta of -0.17, suggesting that its share price is 117% less volatile than the S&P 500. Comparatively, NantHealth has a beta of 1.82, suggesting that its share price is 82% more volatile than the S&P 500.
CURRENC Group has a net margin of 0.00% compared to NantHealth's net margin of -94.67%.
In the previous week, CURRENC Group had 1 more articles in the media than NantHealth. MarketBeat recorded 3 mentions for CURRENC Group and 2 mentions for NantHealth. NantHealth's average media sentiment score of 0.00 beat CURRENC Group's score of -0.75 indicating that NantHealth is being referred to more favorably in the news media.
56.0% of CURRENC Group shares are owned by institutional investors. Comparatively, 4.5% of NantHealth shares are owned by institutional investors. 17.8% of CURRENC Group shares are owned by company insiders. Comparatively, 61.3% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
CURRENC Group has higher earnings, but lower revenue than NantHealth.
CURRENC Group currently has a consensus target price of $3.50, indicating a potential upside of 570.24%. Given CURRENC Group's stronger consensus rating and higher probable upside, analysts clearly believe CURRENC Group is more favorable than NantHealth.
Summary
CURRENC Group beats NantHealth on 9 of the 14 factors compared between the two stocks.
Get NantHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
NantHealth Competitors List
Related Companies and Tools
This page (NASDAQ:NH) was last updated on 5/22/2025 by MarketBeat.com Staff